CJEU issues clarification on UK’s pay-for-delay generics ruling

The Court of Justice of the European Union (CJEU) has ruled that pharmaceutical pay-for-delay agreements may violate the Treaty on the Functioning of the European Union (TFEU), in comments passed down on January 30, 2020.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

AG advises CJEU to uphold €94 million pay-for-delay fine

5 June 2020 The advocate general has recommended that the Court of Justice of the European Union uphold an almost €94 million fine imposed on Lundbeck for its pay-for-delay scheme.

Big Pharma

Retirees interest group supports California’s pay-for-delay ban

10 March 2020 The AARP has urged the US Court of Appeals for the Ninth Circuit to uphold a newly-formed California law prohibiting the majority of pay-for-delay pharmaceutical settlements.

Americas

Par avoids pay-for-delay suit after court accepts payment was ‘fair’

10 March 2020 A Virginia judge has approved Par Pharmaceutical’s settlement with a group of direct purchasers, allowing the pharmaceutical company to escape a pay-for-delay lawsuit.

More on this story

Big Pharma

AG advises CJEU to uphold €94 million pay-for-delay fine

5 June 2020 The advocate general has recommended that the Court of Justice of the European Union uphold an almost €94 million fine imposed on Lundbeck for its pay-for-delay scheme.

Big Pharma

Retirees interest group supports California’s pay-for-delay ban

10 March 2020 The AARP has urged the US Court of Appeals for the Ninth Circuit to uphold a newly-formed California law prohibiting the majority of pay-for-delay pharmaceutical settlements.

Americas

Par avoids pay-for-delay suit after court accepts payment was ‘fair’

10 March 2020 A Virginia judge has approved Par Pharmaceutical’s settlement with a group of direct purchasers, allowing the pharmaceutical company to escape a pay-for-delay lawsuit.

More on this story

Big Pharma

AG advises CJEU to uphold €94 million pay-for-delay fine

5 June 2020 The advocate general has recommended that the Court of Justice of the European Union uphold an almost €94 million fine imposed on Lundbeck for its pay-for-delay scheme.

Big Pharma

Retirees interest group supports California’s pay-for-delay ban

10 March 2020 The AARP has urged the US Court of Appeals for the Ninth Circuit to uphold a newly-formed California law prohibiting the majority of pay-for-delay pharmaceutical settlements.

Americas

Par avoids pay-for-delay suit after court accepts payment was ‘fair’

10 March 2020 A Virginia judge has approved Par Pharmaceutical’s settlement with a group of direct purchasers, allowing the pharmaceutical company to escape a pay-for-delay lawsuit.

More features

Life sciences leaders recognised at LSPN Awards USA 2025

UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body

LSPN: Counsel grapple with AI’s impact on training and critical thinking

'Nothing can stand in the way of our work': Ukraine resumes IP system

LSPN: Trump's policy storm causing chaos and confusion

Taylor Wessing expands in Europe with Paris team

LSPN: Using ‘the patentee’s friend’ in Section 112 claims

ResMed voids sleep apnoea tech patent at PTAB

CJEU issues clarification on UK’s pay-for-delay generics ruling

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features